Verastem (VSTM) Other financing activities (2011 - 2026)
Verastem's (VSTM) quarterly Other financing activities came in at $29.4 million in Q1 2026, up 619.35% year-on-year from $4.1 million in Q1 2025, and up 146755.0% quarter-over-quarter from $20000.0 in Q4 2025.
Verastem (VSTM) Other financing activities (2011 - 2026) Analysis & Trends
Verastem's Other financing activities history runs 15 years deep, the most recent figure standing at $29.4 million for Q1 2026.
- On a quarterly basis, Other financing activities rose 619.35% year-over-year to $29.4 million in Q1 2026; TTM through Mar 2026 was $25.4 million, a 41.72% decrease from a year earlier, with the FY2025 full-year figure at $116000.0, down 99.71% from the prior year.
- Other financing activities rose to $29.4 million in Q1 2026 per VSTM's latest filing, from $20000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $39.4 million in Q3 2024 and bottomed at -$13.7 million in Q3 2025.
- The 5-year median for Other financing activities is $92000.0 (2022), against an average of $5.3 million.
- Across the five-year window, Other financing activities soared 140521.43% in 2024 and sank 134.91% in 2025, its largest moves.
- Year by year, Other financing activities stood at $90000.0 in 2022, then sank by 68.89% to $28000.0 in 2023, then surged by 140521.43% to $39.4 million in 2024, then sank by 99.95% to $20000.0 in 2025, then soared by 146755.0% to $29.4 million in 2026.
- Per Business Quant, the three latest VSTM Other financing activities figures stand at $29.4 million (Q1 2026), $20000.0 (Q4 2025), and -$13.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.37 Mn |
| Mar 31, 2026 | 29.37 Mn |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | -13.74 Mn |
| Sep 30, 2025 | -13.74 Mn |
| Jun 30, 2025 | 9.76 Mn |
| Jun 30, 2025 | 9.76 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Mar 31, 2025 | 4.08 Mn |
| Sep 30, 2024 | 39.37 Mn |
| Sep 30, 2024 | 39.37 Mn |
| Jun 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Sep 30, 2023 | 28,000.00 |
| Sep 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Mar 31, 2023 | 29,000.00 |